chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Myalgia, Vaccination site pain
Clinical narrative: shortness of breath; itchy patch under injection; fatigue; body ache; sore; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (itchy patch under injection), FATIGUE (fatigue), MYALGIA (body ache) and VACCINATION SITE PAIN (sore) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (itchy patch under injection), FATIGUE (fatigue), MYALGIA (body ache), VACCINATION SITE PAIN (sore) and CHILLS (chills). At the time of the report, DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (itchy patch under injection), FATIGUE (fatigue), MYALGIA (body ache), VACCINATION SITE PAIN (sore) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: shortness of breath; itchy patch under injection; fatigue; body ache; sore; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (itchy patch under injection), FATIGUE (fatigue), MYALGIA (body ache) and VACCINATION SITE PAIN (sore) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (itchy patch under injection), FATIGUE (fatigue), MYALGIA (body ache), VACCINATION SITE PAIN (sore) and CHILLS (chills). At the time of the report, DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (itchy patch under injection), FATIGUE (fatigue), MYALGIA (body ache), VACCINATION SITE PAIN (sore) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache
Clinical narrative: Weakness; Dizzy spells; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizzy spells) and HEADACHE (Headaches) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included MIRABEGRON (MYRBETRIQ), SIMVASTATIN, APIXABAN (ELIQUIS), OMEPRAZOLE, OLMESARTAN, OLODATEROL, METOPROLOL, POTASSIUM, FUROSEMIDE, AMLODIPINE BESILATE (AMDEPIN) and EPOETIN ALFA (PROCRIT) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizzy spells) and HEADACHE (Headaches). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizzy spells) and HEADACHE (Headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included Tylenol (paracetamol).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Oropharyngeal pain
Clinical narrative: Mild cold symptoms; Mild sore throat; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Mild cold symptoms) and OROPHARYNGEAL PAIN (Mild sore throat) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Mild cold symptoms) and OROPHARYNGEAL PAIN (Mild sore throat). At the time of the report, NASOPHARYNGITIS (Mild cold symptoms) and OROPHARYNGEAL PAIN (Mild sore throat) outcome was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: a red spot the size of a silver dollar at the vaccination site on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (a red spot the size of a silver dollar at the vaccination site on her left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (a red spot the size of a silver dollar at the vaccination site on her left arm). At the time of the report, VACCINATION SITE ERYTHEMA (a red spot the size of a silver dollar at the vaccination site on her left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Diarrhoea, Headache, Myalgia
Clinical narrative: nasal congestion; Diarhhea; cough; fever; chills; Muscle aches; headache; This spontaneous case was reported by a physician and describes the occurrence of NASAL CONGESTION (nasal congestion), DIARRHOEA (Diarhhea), COUGH (cough), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (nasal congestion), DIARRHOEA (Diarhhea), COUGH (cough), PYREXIA (fever), CHILLS (chills), MYALGIA (Muscle aches) and HEADACHE (headache). The patient was treated with ZINC (oral) from 24-Jan-2021 to 07-Feb-2021 for Adverse event, at a dose of 25 mg once a day; VITAMIN C [ASCORBIC ACID] (oral) from 24-Jan-2021 to 07-Feb-2021 for Adverse event, at a dose of 2000 mg once a day and VITAMIN D3 (oral) from 24-Jan-2021 to 07-Feb-2021 for Adverse event, at a dose of 1000 mg once a day. At the time of the report, NASAL CONGESTION (nasal congestion), DIARRHOEA (Diarhhea), COUGH (cough), PYREXIA (fever), CHILLS (chills), MYALGIA (Muscle aches) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, SARS-CoV-2 test: positive (Positive) positive and positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow up was received. Additional events- pyrexia, nasal congestion, chills, headache, myalgia, diarrhea and headache were added. Treatment medications were added.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, SARS-CoV-2 test
Clinical narrative: nasal congestion; Diarhhea; cough; fever; chills; Muscle aches; headache; This spontaneous case was reported by a physician and describes the occurrence of NASAL CONGESTION (nasal congestion), DIARRHOEA (Diarhhea), COUGH (cough), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (nasal congestion), DIARRHOEA (Diarhhea), COUGH (cough), PYREXIA (fever), CHILLS (chills), MYALGIA (Muscle aches) and HEADACHE (headache). The patient was treated with ZINC (oral) from 24-Jan-2021 to 07-Feb-2021 for Adverse event, at a dose of 25 mg once a day; VITAMIN C [ASCORBIC ACID] (oral) from 24-Jan-2021 to 07-Feb-2021 for Adverse event, at a dose of 2000 mg once a day and VITAMIN D3 (oral) from 24-Jan-2021 to 07-Feb-2021 for Adverse event, at a dose of 1000 mg once a day. At the time of the report, NASAL CONGESTION (nasal congestion), DIARRHOEA (Diarhhea), COUGH (cough), PYREXIA (fever), CHILLS (chills), MYALGIA (Muscle aches) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, SARS-CoV-2 test: positive (Positive) positive and positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow up was received. Additional events- pyrexia, nasal congestion, chills, headache, myalgia, diarrhea and headache were added. Treatment medications were added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site haemorrhage, Pain in extremity, Tenderness
Clinical narrative: Bled from injection site; Soreness in right arm; soreness in right arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HAEMORRHAGE (Bled from injection site), TENDERNESS (Soreness in right arm) and PAIN IN EXTREMITY (soreness in right arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Neuropathy.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HAEMORRHAGE (Bled from injection site), TENDERNESS (Soreness in right arm) and PAIN IN EXTREMITY (soreness in right arm). At the time of the report, INJECTION SITE HAEMORRHAGE (Bled from injection site) and TENDERNESS (Soreness in right arm) outcome was unknown and PAIN IN EXTREMITY (soreness in right arm) was resolving.            Consumer reports taking lidocaine patch for neuropathy.  No treatment information was provided.  No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Live follow up received on 20-Apr-2021: Event related information updated: Patient had second shot in right arm and left arm and both arms are still Sore.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Furuncle, Swelling, Vaccination site pain
Clinical narrative: pain on the arm; swelling on both clavicles; pain at the bone and shivers; on the left side a little ball right on top of the left clavicle bone; A spontaneous report was received from a consumer concerning a 46-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events swelling on both clavicles, on the left side a little ball right on top of the left clavicle bone/Furuncle, the swelling doesn't hurt/swelling, it moves each time that tries to touch it, it's like if it is loose, pain at the bone and shivers/Bone pain, pain on the arm/arm pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 027L20A) intramuscularly for prophylaxis of COVID-19 infection. On 5 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Not available) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the event(s) swelling on both clavicles. On the left side a little ball right on top of the left clavicle bone, the swelling doesn't hurt, t it moves each time that tries to touch it, it's like if it is loose, pain at the bone and shivers. On an unknown date, the patient experienced the event(s) pain on the arm.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), swelling on both clavicles, on the left side a little ball right on top of the left clavicle bone, the swelling doesn't hurt, t it moves each time that tries to touch it, it's like if it is loose, pain at the bone and shivers, pain on the arm was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Achy body; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achy body), PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced MYALGIA (Achy body), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, MYALGIA (Achy body), PYREXIA (Fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up information received on 16-Apr-2021 contains non-significant information.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Rash
Clinical narrative: rash on his nose (1/4 of inches); This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on his nose (1/4 of inches)) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 15-Jan-2019 and Anxiety (guessing). Concomitant products included LOSARTAN from 15-Jan-2019 to an unknown date for Blood pressure, MULTIVITAMIN [VITAMINS NOS], WITHANIA SOMNIFERA (ASHWAGANDHA [WITHANIA SOMNIFERA]) from 2018 to an unknown date, VITAMIN D3 and UBIDECARENONE (COQ10 [UBIDECARENONE]) for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced RASH (rash on his nose (1/4 of inches)). On 24-Feb-2021, RASH (rash on his nose (1/4 of inches)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 100 (High) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medications were reported. multivitamin Indiactionis for   well being. COq-10 indication for heart health.   This case was linked to MOD-2021-255653 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Updated patient demographics (Height, weight, Race], medical history.  Added suspect drug is given to left arm. Concomitant medicines .Added Vaccination centre details.   Added  event start date and end date. Updated outcome of events from Unknown to Recovered.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: vomiting; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was reported.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VOMITING (vomiting) and NAUSEA (nausea). On 27-Jan-2021, VOMITING (vomiting) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant  information was  provided. No Treatment information was  provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site rash
Clinical narrative: Rash arm in same arm as injection; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (pain at injection site) and INJECTION SITE RASH (Rash arm in same arm as injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (pain at injection site). On 06-Feb-2021, the patient experienced INJECTION SITE RASH (Rash arm in same arm as injection). On 08-Feb-2021, INJECTION SITE PAIN (pain at injection site) had resolved. At the time of the report, INJECTION SITE RASH (Rash arm in same arm as injection) outcome was unknown. Events for dose 2 of 2      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: massive headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (massive headache) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced HEADACHE (massive headache). At the time of the report, HEADACHE (massive headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 09-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (massive headache) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced HEADACHE (massive headache). At the time of the report, HEADACHE (massive headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Vaccination site erythema
Clinical narrative: first her right cheek is little bit swollen and now the left cheek is also little bit swollen; slight reaction around the site (redness); This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (first her right cheek is little bit swollen and now the left cheek is also little bit swollen) and VACCINATION SITE ERYTHEMA (slight reaction around the site (redness)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (first her right cheek is little bit swollen and now the left cheek is also little bit swollen) and VACCINATION SITE ERYTHEMA (slight reaction around the site (redness)). At the time of the report, SWELLING FACE (first her right cheek is little bit swollen and now the left cheek is also little bit swollen) and VACCINATION SITE ERYTHEMA (slight reaction around the site (redness)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Foot deformity, Headache, Musculoskeletal stiffness
Clinical narrative: stiffness in hands; tightness in hands; toes curling under; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiffness in hands), MUSCULOSKELETAL STIFFNESS (tightness in hands), FOOT DEFORMITY (toes curling under) and HEADACHE (headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (stiffness in hands), MUSCULOSKELETAL STIFFNESS (tightness in hands), FOOT DEFORMITY (toes curling under) and HEADACHE (headache). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiffness in hands), MUSCULOSKELETAL STIFFNESS (tightness in hands), FOOT DEFORMITY (toes curling under) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: Very minor side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Very minor side effects) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced ADVERSE DRUG REACTION (Very minor side effects). The patient was treated with ACETAMINOPHEN ongoing from 19-Jan-2021 for Adverse event following immunisation, at a dose of UNK dosage form. At the time of the report, ADVERSE DRUG REACTION (Very minor side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient took preventatively a dose of acetaminophen in the morning of vaccination.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Panic attack
Clinical narrative: got a little scared; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (got a little scared) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (allergic to sulfa).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PANIC ATTACK (got a little scared). At the time of the report, PANIC ATTACK (got a little scared) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHMA (Asthma but it is intensified today), INJECTION SITE PRURITUS (itchy), INJECTION SITE SWELLING (arm is swollen) and VACCINATION SITE PAIN (arm soreness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included Asthma. Concurrent medical conditions included Shellfish allergy. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm soreness). On 08-Feb-2021, the patient experienced ASTHMA (Asthma but it is intensified today), INJECTION SITE PRURITUS (itchy) and INJECTION SITE SWELLING (arm is swollen). At the time of the report, ASTHMA (Asthma but it is intensified today), INJECTION SITE PRURITUS (itchy), INJECTION SITE SWELLING (arm is swollen) and VACCINATION SITE PAIN (arm soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included patient consulted her doctor and gave her some pills.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Rash at the injection site; Itchy injection site; Really warm injection site; Sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE WARMTH (Really warm injection site) and INJECTION SITE PAIN (Sore injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN & MINERAL for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced INJECTION SITE PAIN (Sore injection site). On 15-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE WARMTH (Really warm injection site). At the time of the report, VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE WARMTH (Really warm injection site) and INJECTION SITE PAIN (Sore injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Chills, Dyspnoea, Feeling abnormal
Clinical narrative: Shortness of breath; Swollen stomach; Upset stomach, still feels sick after they eat; Had to lay on the floor after a bath because they were afraid they couldn't move; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ABDOMINAL DISTENSION (Swollen stomach), ABDOMINAL DISCOMFORT (Upset stomach, still feels sick after they eat), FEELING ABNORMAL (Had to lay on the floor after a bath because they were afraid they couldn't move) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath), ABDOMINAL DISTENSION (Swollen stomach), ABDOMINAL DISCOMFORT (Upset stomach, still feels sick after they eat), FEELING ABNORMAL (Had to lay on the floor after a bath because they were afraid they couldn't move) and CHILLS (Chills). At the time of the report, DYSPNOEA (Shortness of breath), ABDOMINAL DISTENSION (Swollen stomach), ABDOMINAL DISCOMFORT (Upset stomach, still feels sick after they eat), FEELING ABNORMAL (Had to lay on the floor after a bath because they were afraid they couldn't move) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Chills, Herpes zoster, Vaccination site pain
Clinical narrative: Chill; shingles; Loss of taste; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chill), VACCINATION SITE PAIN (Soreness), HERPES ZOSTER (shingles) and AGEUSIA (Loss of taste) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, ATORVASTATIN, METFORMIN and VITAMINS NOS for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness). On 05-Feb-2021, the patient experienced CHILLS (Chill), HERPES ZOSTER (shingles) and AGEUSIA (Loss of taste). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Feb-2021, VACCINATION SITE PAIN (Soreness) had resolved. At the time of the report, CHILLS (Chill) and AGEUSIA (Loss of taste) had not resolved and HERPES ZOSTER (shingles) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: neck was red; face was red; forehead was red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (neck was red), ERYTHEMA (face was red) and ERYTHEMA (forehead was red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and High cholesterol. Concomitant products included TICAGRELOR (BRILINTA), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ROSUVASTATIN, METOPROLOL, RAMIPRIL and VITAMIN D3 for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced ERYTHEMA (neck was red), ERYTHEMA (face was red) and ERYTHEMA (forehead was red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 05-Feb-2021 at a dose of UNK dosage form and PREDNISONE on 05-Feb-2021 at a dose of UNK dosage form. On 05-Feb-2021, ERYTHEMA (neck was red), ERYTHEMA (face was red) and ERYTHEMA (forehead was red) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Bump; Itching; Rash; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Bump), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (Swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Bump), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (Swelling). On 04-Feb-2021, VACCINATION SITE INDURATION (Bump), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE RASH (Rash) and VACCINATION SITE SWELLING (Swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not provided by the reporter. Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: NNI - email response On 10-Jul-2021: Follow up document received on 10 - JUL-2021 contains No New Information
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Pruritus, Urticaria
Clinical narrative: itching started; the arm is still red, but not so red anymore; hives started but went away after 2 days; a little bit sore but it went away; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching started), ERYTHEMA (the arm is still red, but not so red anymore), URTICARIA (hives started but went away after 2 days) and MYALGIA (a little bit sore but it went away) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced MYALGIA (a little bit sore but it went away). On an unknown date, the patient experienced PRURITUS (itching started), ERYTHEMA (the arm is still red, but not so red anymore) and URTICARIA (hives started but went away after 2 days). At the time of the report, PRURITUS (itching started) and ERYTHEMA (the arm is still red, but not so red anymore) had not resolved and URTICARIA (hives started but went away after 2 days) and MYALGIA (a little bit sore but it went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: red rash at injection site rectangular in shape 1 by 2 inches; A spontaneous report was received from a consumer concerning a 80-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events red rash at injection site rectangular in shape 1 by 2 inches.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 051L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 7 Feb 2021, the patient experienced the event(s) red rash at injection site rectangular in shape 1 by 2 inches.  Treatment details included none.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), red rash at injection site rectangular in shape 1 by 2 inches was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Injection site swelling, Vaccination site pruritus
Clinical narrative: injection arm is swollen; injection arm is swollen and extremely itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection arm is swollen) and VACCINATION SITE PRURITUS (injection arm is swollen and extremely itchy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced INJECTION SITE SWELLING (injection arm is swollen) and VACCINATION SITE PRURITUS (injection arm is swollen and extremely itchy). At the time of the report, INJECTION SITE SWELLING (injection arm is swollen) and VACCINATION SITE PRURITUS (injection arm is swollen and extremely itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Feeling abnormal, Myalgia
Clinical narrative: loss of appetite; "just like having COVID-19 infection"; laid in bed; Chlls; body aches; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), CHILLS (Chlls), MYALGIA (body aches), FEELING ABNORMAL ("just like having COVID-19 infection") and ASTHENIA (laid in bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder. Concurrent medical conditions included Hypertension and High cholesterol. Concomitant products included LISINOPRIL for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DECREASED APPETITE (loss of appetite), MYALGIA (body aches), FEELING ABNORMAL ("just like having COVID-19 infection") and ASTHENIA (laid in bed). On an unknown date, the patient experienced CHILLS (Chlls). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (loss of appetite), CHILLS (Chlls), MYALGIA (body aches), FEELING ABNORMAL ("just like having COVID-19 infection") and ASTHENIA (laid in bed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: sore arm; Temp of 100.4 fever; Chills; felt wiped out like fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA (Temp of 100.4 fever), CHILLS (Chills) and FATIGUE (felt wiped out like fatigue) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included ACICLOVIR SODIUM (ACYCLOVIR ABBOTT VIAL), ATORVASTATIN, CARVEDILOL, CLOPIDOGREL, GABAPENTIN, GLIPIZIDE, HYDRALAZINE and LISINOPRIL for an unknown indication, METFORMIN, PANTOPRAZOLE and LIRAGLUTIDE (VICTOZA).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PYREXIA (Temp of 100.4 fever), CHILLS (Chills) and FATIGUE (felt wiped out like fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg three times a day. On 29-Jan-2021, PAIN IN EXTREMITY (sore arm), PYREXIA (Temp of 100.4 fever), CHILLS (Chills) and FATIGUE (felt wiped out like fatigue) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, Body temperature: 100.4 °F (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: Blister on elbow; Rash Leg (R) above ankle; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister on elbow) and RASH (Rash Leg (R) above ankle) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 129L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Previously administered products included for an unreported indication: SHINGRIX. Concurrent medical conditions included Sulfonamide allergy (Sulfa allergy).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced BLISTER (Blister on elbow) and RASH (Rash Leg (R) above ankle). The patient was treated with ZINC OXIDE at an unspecified dose and frequency. At the time of the report, BLISTER (Blister on elbow) and RASH (Rash Leg (R) above ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included High blood pressure medication.     Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Re[porter address and email updated This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 08-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister on elbow) and RASH (Rash Leg (R) above ankle) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 129L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Previously administered products included for an unreported indication: SHINGRIX. Concurrent medical conditions included Sulfonamide allergy (Sulfa allergy).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced BLISTER (Blister on elbow) and RASH (Rash Leg (R) above ankle). The patient was treated with ZINC OXIDE at an unspecified dose and frequency. At the time of the report, BLISTER (Blister on elbow) and RASH (Rash Leg (R) above ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included High blood pressure medication.     Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Re[porter address and email updated
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph nodes above the collar bone have swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph nodes above the collar bone have swollen) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph nodes above the collar bone have swollen). At the time of the report, LYMPHADENOPATHY (Lymph nodes above the collar bone have swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Adverse effects on the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse effects on the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Adverse effects on the vaccine). At the time of the report, ADVERSE REACTION (Adverse effects on the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on my torso that developed within 48 hours of the vaccination, rash on his chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on my torso that developed within 48 hours of the vaccination, rash on his chest) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced RASH (rash on my torso that developed within 48 hours of the vaccination, rash on his chest). On 26-Jan-2021, RASH (rash on my torso that developed within 48 hours of the vaccination, rash on his chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.  Second dose is scheduled for 20Feb2021.